Literature DB >> 21499704

Gastrointestinal features of Parkinson's disease.

Leslie J Cloud1, James G Greene.   

Abstract

Gastrointestinal (GI) symptoms are among the most common nonmotor manifestations of Parkinson's disease (PD), and they have many important ramifications for patients. The purpose of this review is to raise awareness of the full spectrum of GI symptoms in PD which include weight loss, sialorrhea, dysphagia, nausea, constipation, and defecatory dysfunction. We will discuss their practical significance, and outline a clear approach to their evaluation and management. A brief discussion about the impacts of commonly used medical and surgical PD therapies on GI symptom manifestation is also included.

Entities:  

Mesh:

Year:  2011        PMID: 21499704     DOI: 10.1007/s11910-011-0204-0

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  71 in total

1.  Laryngeal deglutition movement in Parkinson's disease.

Authors:  N A Leopold; M C Kagel
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

2.  Radiological assessment of dysphagia in Parkinson's disease.

Authors:  J Stroudley; M Walsh
Journal:  Br J Radiol       Date:  1991-10       Impact factor: 3.039

3.  Gastric emptying time and gastric motility in patients with Parkinson's disease.

Authors:  R Hardoff; M Sula; A Tamir; A Soil; A Front; S Badarna; S Honigman; N Giladi
Journal:  Mov Disord       Date:  2001-11       Impact factor: 10.338

4.  Effect of swallowing training on swallowing disorders in Parkinson's disease.

Authors:  M Nagaya; T Kachi; T Yamada
Journal:  Scand J Rehabil Med       Date:  2000-03

Review 5.  Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology.

Authors:  L L Edwards; E M Quigley; R F Pfeiffer
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

6.  Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment.

Authors:  F Cadeddu; A R Bentivoglio; F Brandara; G Marniga; G Brisinda; G Maria
Journal:  Aliment Pharmacol Ther       Date:  2005-11-15       Impact factor: 8.171

7.  Colonic transit time and rectoanal videomanometry in Parkinson's disease.

Authors:  R Sakakibara; T Odaka; T Uchiyama; M Asahina; K Yamaguchi; T Yamaguchi; T Yamanishi; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

Review 8.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Ronald F Pfeiffer
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

9.  Weight changes associated with unilateral STN DBS and advanced PD.

Authors:  Harrison C Walker; Michael Lyerly; Gary Cutter; Johnson Hagood; Natividad P Stover; Stephanie L Guthrie; Barton L Guthrie; Ray L Watts
Journal:  Parkinsonism Relat Disord       Date:  2009-03-09       Impact factor: 4.891

10.  Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.

Authors:  Roberta Zangaglia; Emilia Martignoni; Margaret Glorioso; Maria Ossola; Giulio Riboldazzi; Daniela Calandrella; Gabriele Brunetti; Claudio Pacchetti
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

View more
  21 in total

1.  New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.

Authors:  H Karasawa; C Pietra; C Giuliano; S Garcia-Rubio; X Xu; S Yakabi; Y Taché; L Wang
Journal:  Neurogastroenterol Motil       Date:  2014-10-19       Impact factor: 3.598

Review 2.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Delaram Safarpour; Kaveh Sharzehi; Ronald F Pfeiffer
Journal:  Drugs       Date:  2022-01-25       Impact factor: 9.546

3.  Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders.

Authors:  Parvin Oroojzadeh; Saber Yari Bostanabad; Hajie Lotfi
Journal:  J Mol Neurosci       Date:  2022-07-18       Impact factor: 2.866

Review 4.  Parkinson's disease: Are gut microbes involved?

Authors:  Yogesh Bhattarai; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-02       Impact factor: 4.052

Review 5.  Ghrelin and Neurodegenerative Disorders-a Review.

Authors:  Limin Shi; Xixun Du; Hong Jiang; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-01-26       Impact factor: 5.590

6.  Enteric Neurodegeneration is Mediated Through Independent Neuritic and Somal Mechanisms in Rotenone and MPP+ Toxicity.

Authors:  Daniel M Virga; Jessica Capps; Bhupinder P S Vohra
Journal:  Neurochem Res       Date:  2018-09-27       Impact factor: 3.996

7.  Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms.

Authors:  Maria G Cersosimo; Gabriela B Raina; Cristina Pecci; Alejandro Pellene; Cristian R Calandra; Cristiam Gutiérrez; Federico E Micheli; Eduardo E Benarroch
Journal:  J Neurol       Date:  2012-12-21       Impact factor: 4.849

Review 8.  Gastrointestinal dysfunction in the synucleinopathies.

Authors:  Kathryn A Chung; Ronald F Pfeiffer
Journal:  Clin Auton Res       Date:  2020-11-27       Impact factor: 4.435

Review 9.  Neurodegenerative disorders and gut-brain interactions.

Authors:  Alpana Singh; Ted M Dawson; Subhash Kulkarni
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

10.  Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson's Disease I-III H&Y Stage.

Authors:  A A Pilipovich; O V Vorob'eva; S A Makarov; N N Shindryaeva; Yu D Vorob'eva
Journal:  Parkinsons Dis       Date:  2022-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.